Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

107 ArticlesKrishna Appala

10 / 11

The Walking Dead – Zombie Stocks That Still Trade

Remember George Costanza’s quote from Seinfeld – It’s a show about Nothing. In today’s post let’s talk about the same topic – Nothing. Companies ...
Image-18-11-20-at-7.51-PM.jpeg

Bectors Food IPO – Should you invest?

In the recent past, Contract manufacturing as a segment has gained investor attention. We now have a new kid on the block.  Mrs. Bectors Foods opens for ...
Variant-2-2.jpg

ICICI Pru Life Insurance – Demystifying the life insurance sector

Understanding the Insurance business has been an Achilles heel for many investors. The reasons can be many. We can't analyse them using our traditional ...
Image-25-11-20-at-6.16-PM.jpeg

LT Multicap Monthly Fact Sheet: Nov 2020

The Multicap portfolio returned 15.4% in November, a reasonable alpha over the 11.4% by the Nifty. Here's a summary of the portfolio's November performance and ...
Multicap_FeaturedImage.jpg

CM Multicap Portfolio: 12 out of 15 stocks deliver strong earnings growth in Q2 – The Report Card

A round up of Q2 Earnings reports of Capitalmind LongTerm Multicap Portfolio ...
Earnings-Report-1.jpg

How have Index Inclusions & Exclusions performed?

How does getting added to or getting removed from the NIFTY affect a stock's performance? Should you buy index inclusions for the passive inflows that will ...
Featured-Image-13.jpeg

Gland Pharma IPO: Should you invest?

Hyderabad based Gland Pharma will be launching the biggest IPO in Indian Pharma sector on 9th November. It’s one of the fastest growing B2B player in the ...
Gland-pharma-Featured-image-2.jpg

Strong performance backed by Gold Loan Growth for Manappuram

One of our LT Multi-cap holdings Manappuram Finance had come up with strong set of numbers. Consolidated AUM is up by 18.6% YoY to 26,900 Cr. Gold AUM is up ...
Earnings-Report-1.jpg

Q2FY21 Earnings: High Performance from High Voltage for KEI Industries

Highlights of KEI Industries Q2FY21 Earnings: Revenue was down -16% YoY to Rs 1036.94 Cr. The company has a strong order book of 2663 Cr as of 31st Oct ...
Earnings-Report-1.jpg

LT Multicap Monthly Fact Sheet: Oct 2020

October 2020 Monthly Update for the LongTerm Multicap Portfolio The Monthly Multicap Portfolio Factsheet will focus on Summarising the performance over the ...
Multicap_FeaturedImage.jpg